Skip to main content
logo
Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India flag India · Delayed Price · Currency is INR
1,252.00
-29.70 (-2.32%)
Mar 30, 2026, 3:29 PM IST

Dr. Reddy's Laboratories Revenue

Dr. Reddy's Laboratories had revenue of 87.27B INR in the quarter ending December 31, 2025, with 4.41% growth. This brings the company's revenue in the last twelve months to 345.83B, up 11.09% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.

Revenue (ttm)
345.83B
Revenue Growth
+11.09%
P/S Ratio
3.09
Revenue / Employee
12.44M
Employees
27,811
Market Cap
1.07T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025325.54B46.37B16.61%
Mar 31, 2024279.16B33.29B13.54%
Mar 31, 2023245.88B31.49B14.69%
Mar 31, 2022214.39B24.67B13.00%
Mar 31, 2021189.72B15.12B8.66%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aurobindo Pharma331.82B
Cipla279.67B
Zydus Lifesciences260.89B
Glenmark Pharmaceuticals165.10B
Alkem Laboratories142.53B
Mankind Pharma139.14B
Divi's Laboratories103.14B
Ipca Laboratories95.06B
Revenue Rankings

Dr. Reddy's Laboratories News

More News